Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07469761

MultidISciplinary Care paThway tailoRed on frAilty in Cancer Patients Referred to Outpatient paLliative Care

The goal of this clinical trial is to learn whether a structured, Patient-Reported Outcome Measures (PROMs)-tailored palliative care pathway improves clinical outcomes and care experience in adults with advanced cancer referred to outpatient palliative care.

Patients with advanced cancer often experience multiple symptoms and complex needs. Standard outpatient palliative care is usually guided by clinical judgment on patient-reported questionnaires. In this study, researchers aim to test whether a more structured approach, based on predefined cut-offs from PROMs, can improve symptom control, satisfaction with care, and use of healthcare resources. The main questions the study aims to answer are:

Does a structured, PROM-driven palliative care pathway reduce symptom burden and psychological distress compared with usual care? And through this, to improve patients' and caregivers' satisfaction with care or reduce emergency room visits, hospital admissions, healthcare costs, and aggressive treatments near the end of life?

Researchers will compare two groups:

Control group: Participants will receive standard outpatient palliative care. PROMs are collected as usual, but without predefined cut-offs or structured intervention checklists.

Experimental group: Participants will receive a structured palliative care pathway tailored to symptoms/needs identified at baseline using PROM cut-offs. Specific multidisciplinary interventions are activated according to identified needs.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Palliative Care Cancer Frailty Neoplasms Outpatient Palliative Care, Health Services Pathologic Processes Pathological Conditions, Signs and Symptoms Patient Reported Outcome (PRO) Patient Reported Outcome Measurements

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

IRCCS Istituto Nazionale dei Tumori, Via Venezian n1

Milan, Lombardy, 20133, Italy

Location status: Recruiting

Location contact

Giacomo Massa, Dr

CONTACT

[email protected]

+39 0223903279/3272

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • diagnosis of advanced/metastatic cancer
  • age > 18
  • Eastern Cooperative Oncology Group (ECOG) performance status ≥2
  • prognostic clinical prediction >1 month.

Exclusion criteria

  • Serious medical or psychiatric illness that can interfere with informed consent and participation in this clinical study
  • any condition that is unstable or could jeopardize the safety of the patient and their compliance in the study.

Treatment and study plan

Structured Palliative Care

Other

Symptoms/needs domains are defined according to protocol-specified cut-offs, followed by the activation of a tailored intervention based on structured checklists targeting the reported symptoms/needs.

Classical Palliative Care

Other

Multidisciplinary palliative care interventions are delivered according to usual clinical practice, without activation based on predefined cut-offs or structured algorithms.

Primary outcomes

  1. Change in overall symptom burden assessed by the ESAS.

    Time frame: 1, 3 months

    • Mean change in symptom burden from baseline to 1 month after initiation of palliative care, measured using the Edmonton Symptom Assessment System (ESAS) total score (range 0-90, higher scores indicating greater symptom burden). The analysis will compare the change in ESAS total score between the two randomized groups.

  2. Change in psychological distress assessed by the Distress Thermometer (DT).

    Time frame: 1, 3 Months

    Mean change in psychological distress from baseline to 1 month after initiation of palliative care, measured using the Distress Thermometer (DT) (range 0-10, higher scores indicating greater distress). The analysis will compare the change in DT score between the two randomized groups.

Secondary outcomes

  1. Patients' satisfaction with care

    Time frame: 1, 3 months

    The higher satisfaction with care after a structured intervention based on baseline PROMs. Endpoints: improvement in satisfaction with care measured by FAMCARE (Family Satisfaction with Advanced Cancer Care)-P13. This self-administered questionnaire utilizes a 5-point Likert scale (from 1 = "very dissatisfied" to 5 = "very satisfied"), range 0-65, where the total score is directly proportional to satisfaction levels (higher scores indicate more satisfaction).

  2. Healthcare resource utilization

    Time frame: 3, 6 months

    the differences between the experimental and control groups concerning the number of total visits, emergency room admissions, and urgent hospital admissions during the follow-up

  3. Differeces in End of Life (EoL) care aggressiveness criteria

    Time frame: 3, 6 months

    the differences between the experimental and control groups concerning the number of emergency room admissions, oncological therapy (radiotherapy, surgery, systemic), and hospitalizations occurring within 30 days of death (end of life, EoL).

  4. Caregivers' satisfaction with care

    Time frame: 1, 3 months

    The higher satisfaction with care after a structured intervention based on baseline PROMs. Endpoints: improvement in satisfaction with care, measured by FAMCARE (Family Satisfaction with Advanced Cancer Care). This self-administered questionnaire utilizes a 5-point Likert scale (from 1 = "very dissatisfied" to 5 = "very satisfied"), range 0-85, where the total score is directly proportional to satisfaction levels (higher scores indicate more satisfaction).

Study contacts

Contact information is provided by the study sponsor or research team.

Giacomo Massa, Dr

CONTACT

[email protected]

+39 0223903279/3272

Sponsors and collaborators

Lead sponsor

Augusto Caraceni

Other

Registry information

Acronym: MISTRAL

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Mar 13, 2026
Registry last updated
Mar 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.